# Preventive Treatment of Tacrolimus Ointment in Children With Atopic Dermatitis

> **NCT01745159** · PHASE4 · COMPLETED · sponsor: **Astellas Pharma China, Inc.** · enrollment: 125 (actual)

## Conditions studied

- Moderate/Severe Atopic Dermatitis

## Interventions

- **DRUG:** tacrolimus

## Key facts

- **NCT ID:** NCT01745159
- **Lead sponsor:** Astellas Pharma China, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 125 (ACTUAL)
- **Last updated:** 2014-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01745159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01745159, "Preventive Treatment of Tacrolimus Ointment in Children With Atopic Dermatitis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01745159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*